| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/20/2009 | CA2714254A1 Heterocyclic antiviral compounds |
| 08/20/2009 | CA2713404A1 Pyrimidylmethyl sulfonamide compounds |
| 08/19/2009 | EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2089383A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 08/19/2009 | EP2089380A1 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors |
| 08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 08/19/2009 | EP2088860A1 Chemokine receptor binding compounds |
| 08/19/2009 | EP1846379B1 Antidiabetic bicyclic compounds |
| 08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
| 08/19/2009 | EP1791837B1 Substituted hydantoins for the treatment of cancer |
| 08/19/2009 | EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 08/19/2009 | EP1635824B1 5-membered heterocycle-based p-38 inhibitors |
| 08/19/2009 | EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 08/19/2009 | EP0774122B1 Merocyanine dye protein stains |
| 08/19/2009 | CN101511827A Pyridin-4-yl derivatives as immunomodulating agents |
| 08/19/2009 | CN101511802A Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 08/19/2009 | CN101511429A Indulines derivatives and gpr119 agonists |
| 08/19/2009 | CN101508694A Fine purification method for ampiroxicam |
| 08/19/2009 | CN101508674A Benazepine-2-ketone compound containing ethylene imine ring, preparation and application thereof |
| 08/19/2009 | CN100528871C Benzothiazole derivatives as adenosine receptor ligands |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576221 Substituted imidazole derivatives |
| 08/18/2009 | US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576109 5-{4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-3H-[1,3,4]oxadiazol-2-one; agonists and antiagonists; demylination diseases; metabolic diseases; antidiabetic agents (type 2); syndrom X; asthma; osteoarthritis; lupus; antiinflammatory agents; cardiovascular disorders; cachexia |
| 08/18/2009 | US7576108 Substituted arylcyclopropylacetamides as glucokinase activators |
| 08/18/2009 | US7576100 Muscarinic agonists |
| 08/18/2009 | US7576089 CCR2 or CCR5 receptor antagonists; atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis, cancer, multiple sclerosis, HIV infection; e.g. N-(2-((3S)-3-[(4-Hydroxy-4-phenylcyclohexyl)amino]pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide |
| 08/18/2009 | US7576088 Benzodioxole derivatives |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576078 Tetrahydroquinoline analogues as muscarinic agonists |
| 08/18/2009 | US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine) |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099929A1 Mesoionic pesticides |
| 08/13/2009 | WO2009099853A2 Angiotensin ii receptor antagonists |
| 08/13/2009 | WO2009099110A1 Ultraviolet absorbent, fused ring compound and method for producing the same |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009097695A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | WO2009041705A9 5-membered heterocyclic compounds as proton pump inhibitors |
| 08/13/2009 | WO2009024341A3 Condensed anthran i lami de derivatives as insectisides |
| 08/13/2009 | WO2009007749A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 08/13/2009 | US20090203908 Activator for Peroxisome Proliferator-Activated Receptor |
| 08/13/2009 | US20090203903 Thiazolyl mglur5 antagonists and methods for their use |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203745 Heterocyclic compounds for the inhibition of integrins and use thereof |
| 08/13/2009 | US20090203743 Small molecule entry inhibitors |
| 08/13/2009 | US20090203742 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 08/13/2009 | US20090203715 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 08/13/2009 | US20090203692 Novel chemical compounds |
| 08/13/2009 | US20090202921 Optical recording composition and holographic recording medium |
| 08/13/2009 | US20090202920 Optical recording composition and holographic recording medium |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714966A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | CA2713347A1 Mesoionic pesticides |
| 08/13/2009 | CA2711461A1 Angiotensin ii receptor antagonists |
| 08/12/2009 | EP2086983A2 Fused ring compounds for inflammation and immune-related uses |
| 08/12/2009 | EP2086971A1 Crystalline forms of thiazolidinedione derivative and its manufacturing method |
| 08/12/2009 | EP2086970A2 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 08/12/2009 | EP2086969A1 3-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 08/12/2009 | EP2086965A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 08/12/2009 | EP2086964A2 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 08/12/2009 | EP2086963A2 Hepatitis c virus inhibitors |
| 08/12/2009 | EP2086960A1 Novel inhibitors of glutaminyl cyclase |
| 08/12/2009 | EP2086943A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 08/12/2009 | EP2086938A1 Organic compounds |
| 08/12/2009 | EP2086326A2 Cyclohexenyl-aryl compounds for inflammation and immune-related uses |
| 08/12/2009 | EP1831209B1 Cdc25 phosphatase inhibitors |
| 08/12/2009 | EP1756096B1 Indolyl derivatives as liver-x-receptor modulators |
| 08/12/2009 | EP1682121B1 Use of crth2 antagonist compounds in therapy |
| 08/12/2009 | EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists |
| 08/12/2009 | CN101506204A Human protein tyrosine phosphatase inhibitors and methods of use |
| 08/12/2009 | CN101506203A 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and o |
| 08/12/2009 | CN101506199A Azetidine compounds as orexin receptor antagonists |
| 08/12/2009 | CN101506197A Compound having triazine ring structure substituted with pyridyl group and organic electroluminescent device |
| 08/12/2009 | CN101506195A New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds |
| 08/12/2009 | CN101506183A Human protein tyrosine phosphatase inhibitors and methods of use |
| 08/12/2009 | CN101506180A Human protein tyrosine phosphatase inhibitors and methods of use |
| 08/12/2009 | CN101506176A 2-anilino-4-aminoalkyleneaminopyrimidines |
| 08/12/2009 | CN101506175A 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha |
| 08/12/2009 | CN101506166A Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 08/12/2009 | CN101506155A Biphenyl derivatives and their use in treating hepatitis C |
| 08/12/2009 | CN101503398A Novel sulfide or sulfone containing dianhydride, and preparation and use thereof |
| 08/12/2009 | CN100526310C Cyclopropyl-thienyl-carboxamide as fungicides |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100526298C Amide derivative and medicine |
| 08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/11/2009 | US7572911 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility |
| 08/11/2009 | US7572812 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |